Wegovy® HD (semaglutide) is a new, higher dose for those who may need it. Actor portrayals. Have Wegovy® and ready to start? Actor portrayal. For adults with known heart disease with obesity or …

Apr 1, 2026 · Wegovy (semaglutide) tablets and injections are prescription medications used for weight loss, long-term weight management, and to reduce the risk of major cardiovascular events in certain …

Feb 23, 2026 · Doctors call Wegovy's new weight loss pill a game changer in the fight against obesity, but some experts are urging patients to be cautious. Just weeks after hitting the market, nearly …

Patients pay $149 for each month of 1.5 mg and 4 mg. 4 mg offer only available until August 31, 2026, then $199 per month for 4 mg. Eligibility and restrictions apply. One month defined as 1 bottle of 30 …

Jan 6, 2026 · Wegovy (semaglutide) is a weight-loss medication that comes in both injectable and pill form. Wegovy works by mimicking a natural gut hormone called glucagon-like peptide-1 (GLP-1). It …

Wegovy ® is the only GLP-1 RA indicated for weight loss proven to help prevent life-threatening CV events for adults with established CVD and either overweight or obesity, along with diet and exercise …

Jan 23, 2026 · Yes, it’s possible for Wegovy to cause long-term side effects. This can refer to side effects that last a long time or that develop after long-term use of Wegovy.

Today: Medicare Part D covers Wegovy for obstructive sleep apnea (OSA) — not weight loss. If you have OSA with BMI ≥30 and AHI ≥15, you may qualify now.

Jan 6, 2026 · Patients with a prescription could obtain the starter 1.5 mg dose of the tablet as of Monday, with the higher doses becoming available by the end of the week, according to …

WEGOVY® is a glucagon-like peptide-1 (GLP-1) receptor agonist. WEGOVY® injection is indicated in combination with a reduced calorie diet and increased physical activity: